FP
AMPH icon

Factorial Partners’s Amphastar Pharmaceuticals AMPH Stock Holding History

Factorial Partners’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,900
Closed -$254K – 92
2021
Q4 		$254K Sell
10,900
-28,100
-72% -$575K 0.17% 86
2021
Q3 		$741K Buy
39,000
+19,000
+95% +$372K 0.5% 65
2021
Q2 		$403K Buy
+20,000
New +$377K 0.27% 84

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Factorial Partners's AMPH Position: Q1 2022 in Review

Factorial Partners sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2022, closing a stake of 10,900 shares — an estimated $254K sold.

Factorial Partners first reported a position in AMPH in Q2 2021 and held it in 3 quarters. The position peaked at $741K in Q3 2021. 203 funds tracked by Wall St. Rank hold AMPH as of Q1 2022.

  • Factorial Partners reported no remaining Amphastar Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Factorial Partners sold 10,900 Amphastar Pharmaceuticals shares in Q1 2022, an estimated $254K.
  • Factorial Partners first reported a position in Amphastar Pharmaceuticals in Q2 2021 and held it in 3 quarters.
  • Factorial Partners's Amphastar Pharmaceuticals position peaked at $741K in Q3 2021.
  • 203 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2022.

Based on Factorial Partners's 13F filing for Q1 2022, filed 3 May 2022.